Ankit Agrawal, Aro Daniela Arockiam, Muhammad Majid, Ushasi Saraswati, Joseph El Dahdah, Sanya Chandna, Joseph Kassab, Michel Chedid El Helou, Rishabh Khurana, Tiffany Dong, Mustafa Atar, Elio Haroun, Samer Zakhour, Leonardo Rodriguez, Zoran B Popovic, Nicholas Smedira, Brian P Griffin, Tom Kai Ming Wang
{"title":"Contemporary Clinical Characteristics, Imaging, Management, and Surgical and Nonsurgical Outcomes of Adult Patients With Subaortic Stenosis.","authors":"Ankit Agrawal, Aro Daniela Arockiam, Muhammad Majid, Ushasi Saraswati, Joseph El Dahdah, Sanya Chandna, Joseph Kassab, Michel Chedid El Helou, Rishabh Khurana, Tiffany Dong, Mustafa Atar, Elio Haroun, Samer Zakhour, Leonardo Rodriguez, Zoran B Popovic, Nicholas Smedira, Brian P Griffin, Tom Kai Ming Wang","doi":"10.1161/JAHA.124.036994","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Subaortic stenosis (SAS) is characterized by a fibromuscular membrane located just below the aortic valve, causing fixed outflow tract obstruction. There is a paucity of studies evaluating this condition. This cohort study reviewed the contemporary characteristics and outcomes of SAS in adult patients in a single large referral center.</p><p><strong>Methods and results: </strong>We retrospectively studied adult patients with SAS evaluated at our center during 2011 to 2022. The primary outcome was all-cause mortality and heart failure hospitalizations during follow-up, with secondary end points including recurrence of SAS and repeat surgery after initial SAS surgery. Among 484 patients with SAS, key characteristics included mean age 55±18 years, 67.5% female, left ventricular outflow tract peak velocity 352±140 cm/s and gradient 57±40 mm Hg, left ventricular ejection fraction 60%±14%, 54.8% had prior SAS surgery, and 45.1% had surgery during follow-up. Over a median follow-up of 5.5 (1.5-12.3) years, 11.5% (n=56) died, 6.8% (n=33) had heart failure hospitalizations, 8.0% (n=39) experienced SAS recurrence, and 14 (5.9%) underwent repeat SAS surgery. Multivariable analyses identified older age per 10-years (hazard ratio [HR], 1.37 [95% CI, 1.12-1.68]) and baseline New York Heart Association class (HR, 2.48 [95% CI, 1.54-3.99]) to be statistically significantly associated with the primary end point; higher body mass index, New York Heart Association class, and peak left ventricular outflow tract gradient were also statistically significantly associated with SAS recurrence and redo surgery.</p><p><strong>Conclusions: </strong>Almost half of patients with SAS had surgery in the past or during follow-up, and a significant minority had mortality or morbidity events during follow-up. Identified prognosticators warrant further research to guide management.</p>","PeriodicalId":54370,"journal":{"name":"Journal of the American Heart Association","volume":" ","pages":"e036994"},"PeriodicalIF":5.0000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Heart Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/JAHA.124.036994","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Subaortic stenosis (SAS) is characterized by a fibromuscular membrane located just below the aortic valve, causing fixed outflow tract obstruction. There is a paucity of studies evaluating this condition. This cohort study reviewed the contemporary characteristics and outcomes of SAS in adult patients in a single large referral center.
Methods and results: We retrospectively studied adult patients with SAS evaluated at our center during 2011 to 2022. The primary outcome was all-cause mortality and heart failure hospitalizations during follow-up, with secondary end points including recurrence of SAS and repeat surgery after initial SAS surgery. Among 484 patients with SAS, key characteristics included mean age 55±18 years, 67.5% female, left ventricular outflow tract peak velocity 352±140 cm/s and gradient 57±40 mm Hg, left ventricular ejection fraction 60%±14%, 54.8% had prior SAS surgery, and 45.1% had surgery during follow-up. Over a median follow-up of 5.5 (1.5-12.3) years, 11.5% (n=56) died, 6.8% (n=33) had heart failure hospitalizations, 8.0% (n=39) experienced SAS recurrence, and 14 (5.9%) underwent repeat SAS surgery. Multivariable analyses identified older age per 10-years (hazard ratio [HR], 1.37 [95% CI, 1.12-1.68]) and baseline New York Heart Association class (HR, 2.48 [95% CI, 1.54-3.99]) to be statistically significantly associated with the primary end point; higher body mass index, New York Heart Association class, and peak left ventricular outflow tract gradient were also statistically significantly associated with SAS recurrence and redo surgery.
Conclusions: Almost half of patients with SAS had surgery in the past or during follow-up, and a significant minority had mortality or morbidity events during follow-up. Identified prognosticators warrant further research to guide management.
背景:主动脉瓣下狭窄(SAS)的特征是位于主动脉瓣下方的纤维肌膜导致固定的流出道阻塞。对这种病症进行评估的研究很少。这项队列研究回顾了一家大型转诊中心成年患者 SAS 的当代特征和预后:我们对 2011 年至 2022 年期间在本中心接受评估的 SAS 成年患者进行了回顾性研究。主要结果是随访期间的全因死亡率和心衰住院率,次要终点包括SAS复发和首次SAS手术后的再次手术。在484名SAS患者中,主要特征包括平均年龄(55±18)岁,67.5%为女性,左室流出道峰值速度(352±140)厘米/秒,梯度(57±40)毫米汞柱,左室射血分数(60%±14%),54.8%曾接受过SAS手术,45.1%在随访期间接受过手术。在中位随访 5.5(1.5-12.3)年期间,11.5%(n=56)的患者死亡,6.8%(n=33)的患者心衰住院,8.0%(n=39)的患者 SAS 复发,14(5.9%)的患者再次接受 SAS 手术。多变量分析发现,年龄大于10岁(危险比[HR],1.37[95% CI,1.12-1.68])和基线纽约心脏协会分级(HR,2.48[95% CI,1.54-3.99])与主要终点有显著统计学相关性;较高的体重指数、纽约心脏协会分级和左心室流出道梯度峰值与SAS复发和再次手术也有显著统计学相关性:结论:近一半的SAS患者在过去或随访期间接受过手术,相当一部分患者在随访期间出现死亡或发病情况。已确定的预后指标值得进一步研究,以指导治疗。
期刊介绍:
As an Open Access journal, JAHA - Journal of the American Heart Association is rapidly and freely available, accelerating the translation of strong science into effective practice.
JAHA is an authoritative, peer-reviewed Open Access journal focusing on cardiovascular and cerebrovascular disease. JAHA provides a global forum for basic and clinical research and timely reviews on cardiovascular disease and stroke. As an Open Access journal, its content is free on publication to read, download, and share, accelerating the translation of strong science into effective practice.